Pazopanib Tablet, Film Coated
Product Images NDC 82293-022

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Pazopanib (NDC 82293-022). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novugen Pharma (usa) Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Figure002)

A Kaplan-Meier survival curve showing the proportion of patients progression-free over time in months, comparing pazopanib (N=246) and placebo (N=123). The pazopanib group has a median progression-free duration of 4.6 months, while the placebo group has 1.6 months. The graph includes hazard ratio and confidence interval data for comparison.*

FDA Label Image

Figure (Figure01)

Kaplan-Meier survival curve showing proportion progression-free over time (in months) comparing pazopanib (N=290) to placebo (N=145). The solid line represents pazopanib with a median progression-free duration of 9.2 months, and the dashed line represents placebo with a median of 4.2 months. Hazard ratio is 0.46 with 95% CI (0.34, 0.62) and P value < 0.001.*

FDA Label Image

Label (Image001 V3)

Label for Pazopanib Tablets 200 mg film-coated oral tablets by Novugen Pharma (USA) LLC. The label states each tablet contains 200 mg pazopanib free base equivalent and comes in a package of 120 tablets. Instructions for storage at controlled room temperature and a warning about the safety seal under the cap are included. The package is Rx only.*

FDA Label Image

Chemical Structure (Structure001)

Chemical structure of pazopanib hydrochloride, showing its molecular framework with aromatic rings, nitrogen atoms, methyl groups, and a sulfonamide moiety attached. The image represents the detailed chemical composition of the active ingredient pazopanib hydrochloride.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.